Page last updated: 2024-09-03

ginsenoside rh2 and Osteogenic Sarcoma

ginsenoside rh2 has been researched along with Osteogenic Sarcoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bi, C; Feng, X; Gao, H; Li, C; Yin, J; Zhang, J1
Cai, X; Han, B; Lan, X; Liu, D; Mao, X; Tu, S; Wang, H; Ye, Z; Zhang, Y; Zhang, Z; Zhou, Z; Zuo, G1

Other Studies

2 other study(ies) available for ginsenoside rh2 and Osteogenic Sarcoma

ArticleYear
Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells.
    Journal of biochemical and molecular toxicology, 2020, Volume: 34, Issue:12

    Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Ginsenosides; Humans; In Situ Nick-End Labeling; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinases; NF-kappa B; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases

2020
Integrated bioinformatic analysis and experiment confirmation of the antagonistic effect and molecular mechanism of ginsenoside Rh2 in metastatic osteosarcoma.
    Journal of pharmaceutical and biomedical analysis, 2021, Jul-15, Volume: 201

    Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Computational Biology; Ginsenosides; Humans; Osteosarcoma; Phosphatidylinositol 3-Kinases

2021